Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2024

Accounting Policies [Abstract]

Schedule of Cash and Cash Equivalents

The following table provides a reconciliation of cash, cash equivalents and restricted cash within the condensed consolidated balance sheets that sum to the total of the same on the condensed consolidated statement of cash flows (in thousands):

	September 30, 2024		December 31, 2023
Cash and cash equivalents	$	146,175	$	245,278
Restricted cash	6,143		6,142
Total cash, cash equivalents and restricted cash	$	152,318	$	251,420

Schedule of Restrictions on Cash and Cash Equivalents

The following table provides a reconciliation of cash, cash equivalents and restricted cash within the condensed consolidated balance sheets that sum to the total of the same on the condensed consolidated statement of cash flows (in thousands):

	September 30, 2024		December 31, 2023
Cash and cash equivalents	$	146,175	$	245,278
Restricted cash	6,143		6,142
Total cash, cash equivalents and restricted cash	$	152,318	$	251,420

Schedule of Earnings Per Share, Basic and Diluted

The following table presents the calculation of basic and diluted net loss per share (in thousands, except shares and per share data):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2024		2023		2024		2023
Basic loss per share:
Net loss from continuing operations	$	(54,684)	$	(84,485)	$	(136,846)	$	(222,062)
Less: net loss attributable to non-controlling interest	425		5		1,454		26
Net loss from continuing operations available to common shareholders	(54,259)		(84,480)		(135,392)		(222,036)
Net income from discontinued operations, net of tax	1,836		669		1,687		4,672
Net loss attributable to common shareholders	$	(52,423)	$	(83,811)	$	(133,705)	$	(217,364)
Shares used in computation:
Weighted-average common shares outstanding	331,582,813		292,693,961		314,126,997		270,078,947
Basic and diluted loss per share from continuing operations	$	(0.17)	$	(0.29)	$	(0.44)	$	(0.82)
Basic and diluted income per share from discontinued operations	$	0.01	$	—	$	0.01	$	0.02
Basic and diluted loss per share	$	(0.16)	$	(0.29)	$	(0.43)	$	(0.80)

Schedule of Antidilutive Securities Excluded from Computation of Earnings per Share

The following common share equivalents are excluded from the calculation of weighted average common shares outstanding because their inclusion would have been anti-dilutive:

	September 30,
	2024	2023
Warrants to purchase common stock	166,670	166,670
Stock options	18,846,277	19,103,190
Unvested restricted stock units	22,284,523	14,090,914
Convertible notes variable settlement feature	48,771,938	6,966,078
Total	90,069,408	40,326,852